Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers incl... Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company. The Company is engaged in the advancement of treatment applications for cancers throughout the body. It is a producer of Cesium-131 brachytherapy seeds. These seeds are designed to treat a variety of cancers including prostate cancer, head and neck, lung and brain. The Company has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The Company is also engaged in the development of imaging diagnostics (Pb-203 (Lead-203)). The Company's melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions. Show more
SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...
Anticipates multiple clinical updates in the next 12-18 months, including further progress from two ongoing clinical programs and initiation of therapeutic dosing of one new asset based on its...
SEATTLE, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...
SEATTLE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc.Β (βPerspectiveβ or the βCompanyβ) (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.47 | 14.3292682927 | 3.28 | 3.76 | 3.02 | 1008389 | 3.4119997 | CS |
4 | 0.55 | 17.1875 | 3.2 | 3.76 | 2.96 | 1046847 | 3.37489395 | CS |
12 | -7.65 | -67.1052631579 | 11.4 | 12.9 | 2.7 | 1642827 | 4.36180015 | CS |
26 | -9.14 | -70.9076803724 | 12.89 | 16.55 | 2.7 | 1158376 | 7.81249186 | CS |
52 | -0.947 | -20.1618054077 | 4.697 | 19.05 | 2.7 | 2582398 | 12.12706953 | CS |
156 | -0.013 | -0.345469040659 | 3.763 | 19.05 | 2.05 | 1720239 | 10.49637418 | CS |
260 | -0.013 | -0.345469040659 | 3.763 | 19.05 | 2.05 | 1720239 | 10.49637418 | CS |
Symbol | Price | Vol. |
---|---|---|
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 33.93 (-3.47%) | 1.43M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | $ 17.46 (3.31%) | 1.38M |
MSTUT Rex 2X Long MSTR Daily Target ETF | $ 11.40 (-4.52%) | 1.34M |
TSLZT Rex 2X Inverse Tesla Daily Target ETF | $ 2.235 (0.68%) | 947.19k |
ETHU2x Ether ETF | $ 6.85 (-3.11%) | 918.01k |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.